Equities

Certara Inc

Certara Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)10.93
  • Today's Change0.10 / 0.92%
  • Shares traded1.19m
  • 1 Year change-21.82%
  • Beta1.5084
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Certara Inc had net income fall from a gain of 14.73m to a loss of 55.36m despite a 5.57% increase in revenues from 335.64m to 354.34m. An increase in the selling, general and administrative costs as a percentage of sales from 29.35% to 35.96% was a component in the falling net income despite rising revenues.
Gross margin59.01%
Net profit margin-21.64%
Operating margin-19.69%
Return on assets-5.06%
Return on equity-7.35%
Return on investment-5.46%
More ▼

Cash flow in USDView more

In 2023, Certara Inc did not generate a significant amount of cash. However, the company earned 82.76m from its operations for a Cash Flow Margin of 23.35%. In addition the company used 79.55m on investing activities and also paid 9.45m in financing cash flows.
Cash flow per share-0.1042
Price/Cash flow per share--
Book value per share6.49
Tangible book value per share-0.8409
More ▼

Balance sheet in USDView more

Certara Inc has a Debt to Total Capital ratio of 22.14%, a lower figure than the previous year's 26.35%.
Current ratio2.61
Quick ratio--
Total debt/total equity0.2843
Total debt/total capital0.2214
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.